Adaptive, Group Sequential Designs that Balance the Benefits and Risks of Wider Inclusion Criteria
暂无分享,去创建一个
Michael Rosenblum | Daniel F. Hanley | Richard E. Thompson | Brandon Luber | D. Hanley | Brandon S. Luber | R. Thompson | Michael Rosenblum
[1] P. Bauer,et al. Evaluation of experiments with adaptive interim analyses. , 1994, Biometrics.
[2] M J van der Laan,et al. Covariate adjustment in randomized trials with binary outcomes: Targeted maximum likelihood estimation , 2009, Statistics in medicine.
[3] Sue-Jane Wang,et al. Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset , 2007, Pharmaceutical statistics.
[4] A. Tamhane,et al. Multiple Comparison Procedures , 2009 .
[5] Qing Liu,et al. On Adaptive Extensions of Group Sequential Trials for Clinical Investigations , 2008 .
[6] M A Proschan,et al. Designed extension of studies based on conditional power. , 1995, Biometrics.
[7] Michael A. Proschan,et al. A Unified Theory of Two-Stage Adaptive Designs , 2002 .
[8] Lisa V. Hampson,et al. Group sequential tests for delayed responses (with discussion) , 2013 .
[9] Scott S Emerson,et al. Issues in the use of adaptive clinical trial designs , 2006, Statistics in medicine.
[10] F. Götze. On the Rate of Convergence in the Multivariate CLT , 1991 .
[11] A. Genz,et al. Computation of Multivariate Normal and t Probabilities , 2009 .
[12] Sue-Jane Wang,et al. Adaptive patient enrichment designs in therapeutic trials , 2009, Biometrical journal. Biometrische Zeitschrift.
[13] D. Hanley,et al. Preliminary findings of the minimally-invasive surgery plus rtPA for intracerebral hemorrhage evacuation (MISTIE) clinical trial. , 2008, Acta neurochirurgica. Supplement.
[14] P. O'Brien,et al. A multiple testing procedure for clinical trials. , 1979, Biometrics.
[15] A. Egberts,et al. Optimizing trial design in pharmacogenetics research: comparing a fixed parallel group, group sequential, and adaptive selection design on sample size requirements , 2013, Pharmaceutical statistics.
[16] Christopher Jennison,et al. An improved method for deriving optimal one-sided group sequential tests , 1992 .
[17] R. Simes,et al. An improved Bonferroni procedure for multiple tests of significance , 1986 .
[18] Tim Friede,et al. Adaptive Designs for Confirmatory Clinical Trials with Subgroup Selection , 2014, Journal of biopharmaceutical statistics.
[19] B. Turnbull,et al. Group Sequential Methods with Applications to Clinical Trials , 1999 .
[20] Frank Bretz,et al. Confirmatory adaptive designs with Bayesian decision tools for a targeted therapy in oncology , 2009, Statistics in medicine.
[21] M. J. van der Laan,et al. Optimizing randomized trial designs to distinguish which subpopulations benefit from treatment. , 2011, Biometrika.
[22] Nigel Stallard,et al. Group-Sequential Methods for Adaptive Seamless Phase II/III Clinical Trials , 2011, Journal of biopharmaceutical statistics.
[23] J. Rice. Mathematical Statistics and Data Analysis , 1988 .
[24] Eric V. Slud,et al. Two-Sample Repeated Significance Tests Based on the Modified Wilcoxon Statistic , 1982 .
[25] E. Russek-Cohen,et al. Evaluating treatments when a gender by treatment interaction may exist. , 1997, Statistics in medicine.
[26] W. Lehmacher,et al. Adaptive Sample Size Calculations in Group Sequential Trials , 1999, Biometrics.
[27] Harris A. Jaffee,et al. INTERADAPT -- AN INTERACTIVE TOOL FOR DESIGNING AND EVALUATING RANDOMIZED TRIALS WITH ADAPTIVE ENROLLMENT CRITERIA , 2014, 1404.0734.
[28] Bart Spiessens,et al. Adjusted significance levels for subgroup analyses in clinical trials. , 2010, Contemporary clinical trials.
[29] Christopher Jennison,et al. Adaptive Seamless Designs: Selection and Prospective Testing of Hypotheses , 2007, Journal of biopharmaceutical statistics.
[30] T. Friede,et al. A conditional error function approach for subgroup selection in adaptive clinical trials , 2012, Statistics in medicine.
[31] Frederick Mosteller,et al. Selected quantitative techniques and attitude measurement , 1954 .
[32] C. Jennison,et al. An adaptive seamless phase II/III design for oncology trials with subpopulation selection using correlated survival endpoints † , 2011, Pharmaceutical statistics.
[33] K. K. Lan,et al. Discrete sequential boundaries for clinical trials , 1983 .
[34] C. Dunnett. A Multiple Comparison Procedure for Comparing Several Treatments with a Control , 1955 .
[35] Frank Bretz,et al. Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: General Concepts , 2006, Biometrical journal. Biometrische Zeitschrift.
[36] S. Holm. A Simple Sequentially Rejective Multiple Test Procedure , 1979 .
[37] Y. Hochberg. A sharper Bonferroni procedure for multiple tests of significance , 1988 .
[38] Frank Bretz,et al. Confirmatory Seamless Phase II/III Clinical Trials with Hypotheses Selection at Interim: Applications and Practical Considerations , 2006, Biometrical journal. Biometrische Zeitschrift.